Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $6.92 | Prev. Close $6.39 | Circuit Range N/A |
Day Range $6.92 - $7.46 | Year Range $0.05 - $7.46 | Volume 370 |
Average Traded $7.19 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-Jul-26 | $6.92 | $7.46 | +0.00% |
21-Jul-26 | $6.92 | $7.46 | +16.74% |
20-Jul-26 | $6.36 | $6.39 | +2.65% |
16-Jul-26 | $6.18 | $6.22 | +2.05% |
15-Jul-26 | $6.21 | $6.10 | +1.84% |
14-Jul-26 | $5.99 | $5.99 | +2.04% |
13-Jul-26 | $5.87 | $5.87 | -4.24% |